GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

BACKGROUND: Obesity is related to the loss of skeletal muscle mass and function (sarcopenia). The co-existence of obesity and sarcopenia is called sarcopenic obesity (SO). Glucagon like peptide-1 receptor agonists (GLP-1RA) are widely used in the treatment of diabetes and obesity. However, the prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Jie, Qin, Liyan, Zhong, Jinling, Xia, Ning, Liang, Yuzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439806/
https://www.ncbi.nlm.nih.gov/pubmed/37602204
http://dx.doi.org/10.2147/DMSO.S425642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439806/
https://www.ncbi.nlm.nih.gov/pubmed/37602204
http://dx.doi.org/10.2147/DMSO.S425642

Ejemplares similares